Business Description
Aion Therapeutic Inc
NAICS : 325411
SIC : 3741
ISIN : CA00905T1021
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.17 | |||||
Equity-to-Asset | 0.18 | |||||
Debt-to-Equity | 1.97 | |||||
Debt-to-EBITDA | -2.19 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -5.72 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 47.7 | |||||
3-Year EPS without NRI Growth Rate | 40.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 9.8 | |||||
9-Day RSI | 20.96 | |||||
14-Day RSI | 30.07 | |||||
12-1 Month Momentum % | 100 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.18 | |||||
Quick Ratio | 0.1 | |||||
Cash Ratio | 0.07 | |||||
Days Inventory | 2517.24 | |||||
Days Sales Outstanding | 97 | |||||
Days Payable | 11330.73 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -58.9 | |||||
Shareholder Yield % | -18.83 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 73.87 | |||||
Operating Margin % | -381.98 | |||||
Net Margin % | -494.14 | |||||
FCF Margin % | 51.8 | |||||
ROA % | -76.1 | |||||
ROIC % | -37.4 | |||||
ROC (Joel Greenblatt) % | -505.88 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 10 | |||||
PB Ratio | 3.33 | |||||
EV-to-EBIT | -6.66 | |||||
EV-to-EBITDA | -6.77 | |||||
EV-to-Revenue | 28.38 | |||||
EV-to-FCF | 54.79 | |||||
Earnings Yield (Greenblatt) % | -15.02 | |||||
FCF Yield % | 2.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Aion Therapeutic Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 0.222 | ||
EPS (TTM) (C$) | -0.005 | ||
Beta | -0.12 | ||
Volatility % | 135.03 | ||
14-Day RSI | 30.07 | ||
14-Day ATR (C$) | 0.001736 | ||
20-Day SMA (C$) | 0.01625 | ||
12-1 Month Momentum % | 100 | ||
52-Week Range (C$) | 0.005 - 0.025 | ||
Shares Outstanding (Mil) | 461.55 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Aion Therapeutic Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Aion Therapeutic Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Aion Therapeutic Inc Frequently Asked Questions
What is Aion Therapeutic Inc(XCNQ:AION)'s stock price today?
When is next earnings date of Aion Therapeutic Inc(XCNQ:AION)?
Does Aion Therapeutic Inc(XCNQ:AION) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |